#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac arrest Philadelphia positive acute lymphocytic leukaemia Cerebral haemorrhage Colon cancer Cryoglobulinaemia Desmoid tumour Gaucher's disease type III Chronic graft versus host disease Nephropathy Acute on chronic liver failure IPEX syndrome Neuromyelitis optica spectrum disorder Hypotransferrinaemia Anti-neutrophil cytoplasmic antibody positive vasculitis Eosinophilic oesophagitis More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma recurrent X-linked lymphoproliferative syndrome – Diagnostics Hairy cell leukaemia recurrent Systemic sclerosis pulmonary – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Diagnostics Familial haemophagocytic lymphohistiocytosis – Basic Information Hypereosinophilic syndrome – Diagnostics Carcinoid syndrome – Life with Disease Splenic marginal zone lymphoma – Diagnostics IgA nephropathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bi 3032950 Mometasone Furoate Monohydrate SEPOFARSEN Ecopipam Hydrochloride Riboflavin Sodium Phosphate Micronised Spironolactone Dermatophagoides Pteronyssinus Flucloxacillin Naxitamab Sodium Cromoglicate Paracetamol Ph. Eur. Siponimod Fumaric Acid Ganirelix Fezolinetant Lixudebart Morf-057 Ethanol, Anhydrous Remifentanil Ly3298176 Tecaginlimab More therapies…

    Learn about Your Condition

    Iron deficiency anaemia Type IIa hyperlipidaemia Migraine without aura Ovarian cancer stage IV Juvenile psoriatic arthritis Peritonitis Retinitis pigmentosa Pneumonia Haemoptysis Metastasis Coma Gastrectomy Emphysema Glomerulonephritis membranous Kearns-Sayre syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Staphylococcal infection

  • Study of Continuous Infusion of Cloxacillin Using Elastomeric Pump in Adult Patients with Staphylococcus Aureus Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Cloxacillin Sodium
    Sweden

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • CEFTAROLINE FOSAMIL
    • Delafloxacin
    • Lymecycline
    France

  • Study on the Safety of Inhaled Teicoplanin for Treating Staphylococcus aureus Infections in Cystic Fibrosis Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    • Cystic fibrosis
    Investigated Drugs:
    • Teicoplanin
    Italy

  • Study on How Kidney Function Estimates Help Adjust Cloxacillin Dosing in Patients with Staphylococcus aureus Bacteremia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal bacteraemia
    • Staphylococcal infection
    Investigated Drugs:
    • Cloxacillin
    Sweden

  • Doxycycline post‑exposure prophylaxis for sexually transmitted infections in MSM and transgender women on antiretroviral drug combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Ambroxol Hydrochloride
    • Abacavir
    • Bictegravir
    Spain

  • Study of PP1493 and PP1815 phage therapy for patients with knee or hip joint infections caused by Staphylococcus aureus after prosthetic surgery

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    • Staphylococcal infection
    Investigated Drugs:
    • Pp1493
    • Pp1815
    • Sodium Chloride
    France The Netherlands Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!